The pandemic is steering the venture capital lens away from shorter-term sugar hits found in the technology sector in a “new dawn” for the local life science and biotech fields, one of Australia’s pioneering investors says.
Mr Ferris hopes the incubator and government funding for the sector will kickstart a decade of “health and medical research start-ups” with “IPOs and unicorns that will actually outsize anything in the other industries”. Peter Braig
Loading...
Lucas Baird is a journalist based in The Australian Financial Review's Sydney office. Connect with Lucas on Twitter. Email Lucas at lucas.baird@afr.com
